BICO Group

BICO.STPre-clinical

BICO Group, formerly known as Cellink, is a global life science tools company focused on enabling researchers to automate and scale biological processes. Through strategic acquisitions and organic growth, it has built a comprehensive portfolio spanning bioprinting, liquid handling, cell line development, and advanced imaging. The company's mission is to merge biology with technology to accelerate scientific discovery and improve human health, serving pharmaceutical companies, academic institutions, and biotech firms worldwide.

Market Cap

$123.2M

Employees

800-1200

Focus

Biotech

BICO.ST · Stock Price

USD 16.66152.74 (-90.17%)

Historical price data

AI Company Overview

Technology Platform

An integrated ecosystem of technologies for automating and scaling biological processes, including 3D bioprinting, automated liquid handling, cell line development, and live-cell imaging, connected by software.

Funding History

Total raised: $10M

IPOUndisclosedUndisclosedJun 18, 2021

Series A$10MUndisclosedJun 15, 2018

SeedUndisclosedUndisclosedJun 15, 2016

Opportunities

BICO is positioned to capitalize on the massive trend towards automating and digitizing life science research.

The growing adoption of 3D biology, cell therapies, and biologics creates strong demand for its integrated workflow solutions.

Cross-selling its diverse technologies to a consolidated customer base presents a significant revenue synergy opportunity.

Risk Factors

The company faces significant execution risk in integrating its many acquisitions and realizing promised synergies.

It operates in highly competitive segments against larger, well-funded rivals.

Recent management changes and the path to sustained profitability are key challenges that could impact investor confidence.

Competitive Landscape

BICO competes with giants like Thermo Fisher and Danaher in automation, and niche players in bioprinting and imaging. Its primary differentiation is the strategy of offering an integrated platform connecting bioprinting, cell handling, and analysis, aiming to be a one-stop-shop for labs advancing 3D and complex biology.